SEC Form 4 · accession 0001140361-15-020814
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James R Rusche
Officer — Senior Vice President
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 8:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 15, 2015 | S | 15,000 | $41.3222 | D | 96,849 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$41.3222 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.07 to $41.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.